Pulse Biosciences, Inc (PLSE)
Nasdaq: PLSE · Surgical & Medical Instruments & Apparatus · Hayward, CA · filing with the SEC since 2014
Who owns Pulse Biosciences, Inc
As filed with the SECHolders of 5% or more
1
Robert W. Duggan holds 71.9% of Common Stock, par value $0.001 per share, as its SCHEDULE 13D/A filed May 13, 2026 says.
Directors and officers
11
report now, of 23 people on the record since 2016. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Robert W. Duggan
SCHEDULE 13D/A · filed May 13, 2026 · Common Stock, par value $0.001 per share · 70.6% in Dec 19, 2024
What PLSE reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 19, 2026.
Insider tradesForm 4
8sales
8purchases
8sales on a scheduled plan
1people selling
$3.0Msold, in dollars
$26.8Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 26 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Danahy Kevin Patrick | Chief Commercial Officer | 8 | $3.0M | 8 | 0 | $0 |
| Teplitsky Liane Rae | Chief Operating Officer | 0 | $0 | 0 | 4 | $200,000 |
| Laviolette Paul A | Chief Executive Officer | 0 | $0 | 0 | 2 | $600,000 |
| Duggan Robert W | director | 0 | $0 | 0 | 2 | $26.0M |